These results demonstrate that the biohybrid bacteria engineered with CDH17 targeted nanobodies and the photothermal sensitizer CR can effectively home to tumor tissues highly expressing the target protein CDH17 and can significantly inhibit tumor growth, even in refractory pancreatic cancer. Here, CDH17 is linked to familial pancreatic carcinoma.